vadimezan has been researched along with 3,3'-dioctadecyloxacarbocyanine in 1 studies
| Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (3,3'-dioctadecyloxacarbocyanine) | Trials (3,3'-dioctadecyloxacarbocyanine) | Recent Studies (post-2010) (3,3'-dioctadecyloxacarbocyanine) |
|---|---|---|---|---|---|
| 272 | 16 | 101 | 43 | 0 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Witte, PA; Ni, Y; Van de Putte, M | 1 |
1 other study(ies) available for vadimezan and 3,3'-dioctadecyloxacarbocyanine
| Article | Year |
|---|---|
Exploration of the mechanism underlying the tumor necrosis avidity of hypericin.
Topics: Animals; Anthracenes; Carbocyanines; Female; Fibrosarcoma; Lipoproteins; Mice; Mice, Inbred C3H; Necrosis; Perylene; Sarcoma, Experimental; Xanthones | 2008 |